Study Links Rapid Sepsis Screening to Fewer Admissions and Safer Discharges
A multicenter study found that early sepsis risk testing at triage led to more ED discharges and lower inpatient bed use without compromising patient safety.
A multicenter study found that early sepsis risk testing at triage led to more ED discharges and lower inpatient bed use without compromising patient safety.
VolitionRx's report demonstrated that the Nu.Q NETs sepsis test can predict patients who are at higher risk of deteriorating from sepsis.
Advances in AI and data science highlight innovative machine learning models that predict patient outcomes in multiple myeloma and sepsis.
This method is faster than blood cultures and is less likely to generate false positives compared to other DNA detection-based technologies.
Read MoreDoctors from Norway received test results two days earlier than before when they tested a new way to analyze blood for suspected sepsis.Â
Read MoreA recent review of advances in pediatric sepsis biomarkers provides an overview of research advancements across various omics levels.
Read MoreResearchers harnessed artificial intelligence to analyze data from over 3.5 million children suffering from sepsis.
Read MoreThe Symphony System is designed to address the need for simple, reliable, rapid, near-patient sepsis testing.
Read MoreCytovale detailed the publication of a new peer-reviewed study that highlights the need for rapid sepsis testing.
Read MoreInflammatix says that the U.S. FDA has granted Breakthrough Device Designation for its TriVerity Acute Infection and Sepsis Test System.Â
Read MoreSiemens Healthineers has contracted with the National Institutes of Health (NIH) to improve antibiotic treatment for sepsis patients.
Read MoreThe test system is intended to be used in emergency department settings in patients with suspected acute infection and sepsis.
Read MoreSteripath delivers critical time savings for sepsis diagnosis, improving patient outcomes and providing cost efficiencies.
Read MoreResearch from the Penn State College of Health and Human Development found that a new blood test for sepsis could save lives and money.
Read MoreT2 Biosystems, Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the T2Biothreat Panel.
Read MoreT2 Biosystems praised actions taken by the CDC aimed at optimizing hospital sepsis programs in the United States.
Read MoreCDC Director Mandy Cohen, MD, MPH, is set to release guidelines that offer a roadmap for hospitals to reduce deaths from sepsis.
Read MoreA diagnostic tool that detects sepsis in patients in under 10 minutes is now in use at Our Lady of the Lake Regional Medical Center.
Read More